These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28575807)

  • 1. A holistic review on the autoimmune disease vitiligo with emphasis on the causal factors.
    Patel S; Rauf A; Khan H; Meher BR; Hassan SSU
    Biomed Pharmacother; 2017 Aug; 92():501-508. PubMed ID: 28575807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Problems and prospects of vitiligo study].
    Koshevenko IuN; Frolov EP
    Vestn Dermatol Venerol; 1981; (10):25-30. PubMed ID: 6272508
    [No Abstract]   [Full Text] [Related]  

  • 3. On the etiology of contact/occupational vitiligo.
    Boissy RE; Manga P
    Pigment Cell Res; 2004 Jun; 17(3):208-14. PubMed ID: 15140065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo.
    Kim JY; Lee EJ; Seo J; Oh SH
    Br J Dermatol; 2017 Jun; 176(6):1558-1568. PubMed ID: 27787879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
    Wang Y; Li S; Li C
    Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation.
    Birlea SA; Costin GE; Norris DA
    Curr Drug Targets; 2008 Apr; 9(4):345-59. PubMed ID: 18393827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the etiopathomechanism of vitiligo: a convergence theory.
    Le Poole IC; Das PK; van den Wijngaard RM; Bos JD; Westerhof W
    Exp Dermatol; 1993 Aug; 2(4):145-53. PubMed ID: 8162332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of immune hyporesponsiveness to melanosomal proteins by DHICA-mediated antioxidation: Possible implications for autoimmune vitiligo.
    Liu XM; Zhou Q; Xu SZ; Wakamatsu K; Lei TC
    Free Radic Biol Med; 2011 May; 50(9):1177-85. PubMed ID: 21256957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the etiology of vitiligo and gray hair.
    Lerner AB
    Am J Med; 1971 Aug; 51(2):141-7. PubMed ID: 5095523
    [No Abstract]   [Full Text] [Related]  

  • 13. Vitiligo.
    Kovacs SO
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):647-66; quiz 667-8. PubMed ID: 9591808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?
    Schallreuter KU; Bahadoran P; Picardo M; Slominski A; Elassiuty YE; Kemp EH; Giachino C; Liu JB; Luiten RM; Lambe T; Le Poole IC; Dammak I; Onay H; Zmijewski MA; Dell'Anna ML; Zeegers MP; Cornall RJ; Paus R; Ortonne JP; Westerhof W
    Exp Dermatol; 2008 Feb; 17(2):139-40; discussion 141-60. PubMed ID: 18205713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo.
    Manga P; Sheyn D; Yang F; Sarangarajan R; Boissy RE
    Am J Pathol; 2006 Nov; 169(5):1652-62. PubMed ID: 17071589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current insight into the roles of microRNA in vitiligo.
    Yan S; Shi J; Sun D; Lyu L
    Mol Biol Rep; 2020 Apr; 47(4):3211-3219. PubMed ID: 32086720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff.
    Boissy RE; Spritz RA
    Exp Dermatol; 2009 Jul; 18(7):583-5. PubMed ID: 19320739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo and chronic autoimmune thyroiditis.
    Sandru F; Carsote M; Albu SE; Dumitrascu MC; Valea A
    J Med Life; 2021; 14(2):127-130. PubMed ID: 34104234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.